Glaucoma progression during the COVID-19 pandemics
<p> <b>V.E. Korelina<sup>1</sup>, I.R. Gazizova<sup>2</sup>, A.V. Kuroyedov<sup>3,4</sup>, M.D. Didur<sup>2</sup></b> </p> <p> <b><sup>1</sup>LLC “American Medical Clinic”, St. Petersburg, Russian Feder...
Saved in:
Main Authors: | V.E. Korelina, I.R. Gazizova, A.V. Kuroyedov, M.D. Didur |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Prime-Media
2021-09-01
|
Series: | РМЖ "Клиническая офтальмология" |
Online Access: | http://clinopht.com/upload/iblock/725/725c34fc54e20104ca4496a6141e228e.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brimonidine as an additional treatment for moderate glaucoma
by: I.R. Gazizova, et al.
Published: (2021-05-01) -
State-of-the-art of loading and unloading tests for glaucoma: potentialities and informative value
by: O.S. Myakonkaya, et al.
Published: (2021-09-01) -
Association between instillation time of glaucoma eye drops and their efficacy
by: A.M. Getmanova, et al.
Published: (2020-06-01) -
Role of neuroinflammation in the pathogenesis of glaucomatous optic neuropathy
by: E.A. Egorov, et al.
Published: (2022-05-01) -
Systemic therapy a risk factor for glaucoma development and progression
by: A.M. Getmanova, et al.
Published: (2020-11-01)